Yes, more great news. It's really worth highlighting that the vaccine was just as effective in those over 65 and in all races/ethnicities as in everyone else, as that has been a major concern. I would expect Moderna's results to be similar on the full dataset.
According to Endpoints, the FDA is planning on sharing all vaccine trial data submitted for the EUAs (emergency use authorizations), which will be filed for by both companies shortly - this level of transparency will be important for regulators, medical/public health experts and the public, with regard to inspiring confidence in getting these vaccines.
Endpoints also said the FDA is setting aside time on 12/8-12/10 to review data from both Pfizer and Moderna, presumably to make decisions on their EUAs - assuming that's the case, we should start to see vaccinations starting for front-line workers before Christmas.
https://endpts.com/covid-19-roundup...vaccine-triggers-quick-immune-response-study/
I'm hopeful the great results will move the needle so that maybe we'll see 60-70% get vaccinated rather than the 50-55% that have been saying they will and that level is important to achieving herd immunity (estimated to be in the 55-80% range).
Also, keep in mind that we've likely seen 15-25% of the population already infected (and now immune, as per my post last night), so not quite as many need to be vaccinated to achieve herd immunity, although even infected/recovered people should get the vaccine to ensure protection against the virus.